Physician profile
Peter Christopher Gottschalk
NPI 1831131176
$317,570.11
in general payments reported to CMS, 2019-2025
26 companies · $45K in 2025
The $45K reported for 2025 was more than what 96% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109K · 2020: $54K · 2021: $13K · 2022: $8,824 · 2023: $25K · 2024: $62K · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $52K · Travel and Lodging: $43K · Consulting Fee: $21K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $3,889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $51,758.92 |
| Travel and Lodging | $43,440.89 |
| Consulting Fee | $20,895.07 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,750.00 |
| Food and Beverage | $3,889.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| H. Lundbeck A S | $95,097.39 | 2021-2025 | Vyepti |
| Amgen INC. | $90,132.17 | 2019-2021 | |
| Lundbeck LLC | $28,404.65 | 2019-2025 | Vyepti |
| Lilly USA, LLC | $26,795.56 | 2019-2022 | |
| Abbvie INC. | $21,761.09 | 2022-2025 | |
| Allergan, INC. | $16,739.23 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $7,608.59 | 2019-2022 | |
| Promius Pharma LLC | $6,884.67 | 2019 | |
| Impel Pharmaceuticals LLC | $4,844.78 | 2025 | Trudhesa |
| Biodelivery Sciences International, INC. | $3,000.00 | 2021 | |
| Impel Pharmaceuticals INC. | $2,767.85 | 2022-2023 | Trudhesa |
| Tonix Medicines, INC. | $2,737.97 | 2023-2025 | Zembrace Symtouch |
| Novartis Pharmaceuticals Corporation | $2,612.93 | 2019 | |
| Currax Pharmaceuticals LLC | $2,250.00 | 2021 | |
| Amneal Pharmaceuticals LLC | $2,000.00 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $1,544.33 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $860.00 | 2021 | |
| Dr.Reddy'S Laboratories,INC. | $449.00 | 2022 | |
| Pfizer INC. | $330.49 | 2023-2025 | |
| Biogen, INC. | $207.52 | 2020-2021 | |
| Axsome Therapeutics, INC. | $177.26 | 2025 | Symbravo |
| Siemens Medical Solutions USA, INC. | $171.20 | 2023 | Artis Icono Biplane |
| Avid Radiopharmaceuticals, INC. | $56.08 | 2023-2024 | |
| Assertio Therapeutics, INC. | $53.70 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $50.75 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $32.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Gottschalk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.